Functional Activation of Src Family Kinase Yes Protein Is Essential for the Enhanced Malignant Properties of Human Melanoma Cells Expressing Ganglioside GD3

被引:57
|
作者
Hamamura, Kazunori [1 ]
Tsuji, Momoko [1 ]
Hotta, Hiroshi [1 ,2 ]
Ohkawa, Yuki [1 ]
Takahashi, Masataka [1 ]
Shibuya, Hidenobu [1 ,2 ]
Nakashima, Hideyuki [1 ,2 ]
Yamauchi, Yoshio [1 ]
Hashimoto, Noboru [1 ]
Hattori, Hisashi [2 ]
Ueda, Minoru [2 ]
Furukawa, Keiko [1 ,3 ]
Furukawa, Koichi [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Biochem 2, Nagoya, Aichi 4660065, Japan
[2] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4660065, Japan
[3] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan
关键词
G(D3) SYNTHASE GENE; C-YES; CARCINOMA CELLS; DOWN-REGULATION; LIPID RAFTS; PC12; CELLS; GROWTH; CANCER; PROLIFERATION; LOCALIZATION;
D O I
10.1074/jbc.M110.164798
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The possible roles of Src family kinases in the enhanced malignant properties of melanomas related to GD3 expression were analyzed. Among Src family kinases only Yes, not Fyn or Src, was functionally involved in the increased cell proliferation and invasion of GD3-expressing transfectant cells (GD3+). Yes was located upstream of p130Cas and paxillin and at an equivalent level to focal adhesion kinase. Yes underwent autophosphorylation even before serum treatment and showed stronger kinase activity in GD3+ cells than in GD3- cells following serum treatment. Coimmunoprecipitation experiments revealed that Yes bound to focal adhesion kinase or p130Cas more strongly in GD3+ cells than in GD3-cells. As a possible mechanism for the enhancing effects of GD3 on cellular phenotypes, it was shown that majority of Yes was localized in glycolipid-enriched microdomain/rafts in GD3+ cells even before serum treatment, whereas it was scarcely detected in glycolipid-enriched microdomain/rafts in GD3- cells. An in vitro kinase assay of Yes revealed that coexistence of GD3 with Yes in membranous environments enhances the kinase activity of GD3- cell-derived Yes toward enolase, p125, and Yes itself. Knock-down of GD3 synthase resulted in the alleviation of tumor phenotypes and reduced activation levels of Yes. Taken together, these results suggest a role of GD3 in the regulation of Src family kinases.
引用
收藏
页码:18526 / 18537
页数:12
相关论文
共 42 条
  • [1] GANGLIOSIDE GD3 SHEDDING BY HUMAN-MALIGNANT MELANOMA-CELLS
    BERNHARD, H
    ZUMBUSCHENFELDE, KHM
    DIPPOLD, WG
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) : 155 - 160
  • [2] GANGLIOSIDE GD3 SHEDDING BY CULTURED HUMAN-MALIGNANT MELANOMA-CELLS
    BERNHARD, H
    DIPPOLD, W
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 383 - 383
  • [3] Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2
    Iwasawa, Taiji
    Zhang, Pu
    Ohkawa, Yuki
    Momota, Hiroyuki
    Wakabayashi, Toshihiko
    Ohmi, Yuhsuke
    Bhuiyan, Robiul H.
    Furukawa, Keiko
    Furukawa, Koichi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (04) : 1255 - 1266
  • [4] Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells
    Zou, W
    Borrelli, S
    Gilbert, M
    Liu, TM
    Pon, RA
    Jennings, HJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) : 25390 - 25399
  • [5] Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells
    Hamamura, Kazunori
    Tsuji, Momoko
    Ohkawa, Yuki
    Nakashima, Hideyuki
    Miyazaki, Sayaka
    Urano, Takeshi
    Yamamoto, Noriyuki
    Ueda, Minoru
    Furukawa, Koichi
    Furukawa, Keiko
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2008, 1780 (03): : 513 - 519
  • [6] Ganglioside GD3/GD2 enhance malignant properties of human glioma U251 cells
    Zhang, Pu
    Iwasawa, Taiji
    Ohkawa, Yuki
    Bhuiyan, R. H.
    Momota, Hiroyuki
    Wakabayashi, Toshihiko
    Ohmi, Yuhsuke
    Okajima, Tetsuya
    Furukawa, Keiko
    Furukawa, Koichi
    CANCER SCIENCE, 2018, 109 : 256 - 256
  • [7] GD3 - A MAJOR GANGLIOSIDE OF HUMAN-MALIGNANT MELANOMA - DETECTION BY A MOUSE MONOCLONAL-ANTIBODY
    PUKEL, CS
    LLOYD, KO
    TRAVASSOS, LR
    DIPPOLD, WG
    OETTGEN, HF
    OLD, LJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 273 - 273
  • [8] Compared immunogenicity in mice of GD3 ganglioside purified from human malignant melanoma versus glyco-replica peptides mimicking GD3
    Popa, I
    Ishikawa, D
    Taki, T
    Portoukalian, J
    Thomas, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 521 - 521
  • [9] IMMUNOHISTOLOGICAL ANALYSIS OF GANGLIOSIDE GD3 IN MALIGNANT-MELANOMA - EPITHELIAL TUMORS AND NORMAL HUMAN-TISSUES
    DIPPOLD, W
    DIENES, HP
    KNUTH, A
    ZUMBUSCHENFELDE, KHM
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1985, 109 (02) : A23 - A23
  • [10] Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains
    Ohkawa, Yuki
    Miyazaki, Sayaka
    Hamamura, Kazunori
    Kambe, Mariko
    Miyata, Maiko
    Tajima, Orie
    Ohmi, Yuhsuke
    Yamauchi, Yoshio
    Furukawa, Koichi
    Furukawa, Keiko
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (35) : 27213 - 27223